Cardiac Mitochondrial Research in the Lab of Paul S. Brookes, PhD
(Warning – this post contains swearing. Once you’ve read it you’ll understand why) Anyone who follows mitochondrial research closely will be aware of a phenomenon that’s appeared in the mito’ literature in recent years – namely the concept that mitochondria … Continue reading →
Anyone following developments at NIH will be familiar with a new category for disposition of grant proposals following initial review: CND, competitive not discussed. (Flashback for GenXers like me: not to be confused with CND, the Campaign for Nuclear Disarmament, … Continue reading →
I just posted a new pre-print reporting on a small investigation in the area of image manipulation and research misconduct. It centers on content from the Journal of Cancer, which is published by the Australian open access publisher Ivyspring. The … Continue reading →
This story spans several years between 2010 and 2014. It was sitting in my drafts folder for over a decade, so some links may be dead and the current status of various people or companies or science may no longer … Continue reading →
Continuing the saga of Alan Cash and Terra Biological, trying to get a dietary supplement containing oxaloacetate into clinical trials for all sorts of conditions from long-covid to PMS, there appears to have been a “breakthrough“! The company finally got … Continue reading →